Type to search

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform | Pharmtech Focus | Pharmtech Focus
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units | Pharmtech Focus
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses | Pharmtech Focus